| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
| filingDate |
2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0223e191e391bebc3d5e91cf8a67911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_742ae302b917d2bedd33b19b3cd86c2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d4bdc504501383f2cda9d5327a21abf |
| publicationDate |
2013-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2424753-T3 |
| titleOfInvention |
Pharmaceutical solution formulations for pressurized metered dose inhalers |
| abstract |
A pressurized solution formulation for a metered dose inhaler comprising deformoterol fumarate in combination with beclomethasone dipropionate as active substances dissolved in a mixture consisting of HFA134a propellant and an amount of 12% wt / wt as co-solvent and 0.024 % weight / weight of hydrochloric acid (1 M) for use in the prevention and / or treatment of a bronchopulmonary disease selected from severe persistent asthma or severe or very severe chronic obstructive pulmonary disease (COPD), in which, after the action of said inhaler, 50 μl of said solution comprising deformoterol fumarate are administered at a dose per action of 6 μg and beclomethasone dipropionate at a dose of 100 μg per action. |
| priorityDate |
2006-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |